Clinical Cardiology

View the latest content related to this topic

News Daily News

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the top dose.

L.A. McKeown

August 07, 2025

Slides

See all

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

Presentation ACC 2025

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Presenter: Keyvan Karkouti

March 29, 2025

Presentation Controversies and Advances 2025

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Presenter: Kalyanam Shivkumar

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Presenter: Richard J. Auchus

January 30, 2025

News

See all

News Daily News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

By Todd Neale

August 11, 2025

News Daily News

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

By L.A. McKeown

August 07, 2025

News Daily News

Self-service Kiosks May Aid Population Monitoring of High BP

By Todd Neale

August 07, 2025

News Daily News

US Stroke Rehab System Not Serving Patient Needs, Societies Say

By L.A. McKeown

August 07, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

By Michael O'Riordan

August 06, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Clinical Cardiology

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

Slides

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

Self-service Kiosks May Aid Population Monitoring of High BP

US Stroke Rehab System Not Serving Patient Needs, Societies Say

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content